TABLE 1.
Demographics of 611 participants who completed baseline assessment and serum
Characteristic | N | % |
---|---|---|
Gender | ||
Female | 410 | 67.1 |
Male | 201 | 32.9 |
Age (mean, 47.4) | ||
28–39 | 140 | 22.9 |
40–49 | 229 | 37.5 |
50–59 | 161 | 26.4 |
60–76 | 81 | 13.3 |
Demographics of 611 participants who completed baseline assessment and serum
Characteristic | N | % |
---|---|---|
Gender | ||
Female | 410 | 67.1 |
Male | 201 | 32.9 |
Age (mean, 47.4) | ||
28–39 | 140 | 22.9 |
40–49 | 229 | 37.5 |
50–59 | 161 | 26.4 |
60–76 | 81 | 13.3 |